Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.665 AUD | 0.00% | +5.65% | +28.43% |
04-16 | Euroz Hartleys Adjusts Argenica Therapeutics’ Price Target to AU$1.40 From AU$1.50, Keeps at Speculative Buy | MT |
04-12 | Argenica Therapeutics Raises AU$12 Million via Placement | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+28.43% | 49.87M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- AGN Stock
- News Argenica Therapeutics Limited
- Argenica Therapeutics On Track for First Patient Dosing in Phase 2 ARG-007 Trial in Q1 2024